Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?
Despite being featured as metabolic disorder, diabetic patients are largely affected by hyperglycemia-induced vascular abnormality. Accumulated evidence has confirmed the beneficial effect of endothelial progenitor cells (EPCs) in coronary heart disease. However, antivascular endothelial growth fact...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/1803989 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555104943734784 |
|---|---|
| author | Cai-Guo Yu Ning Zhang Sha-Sha Yuan Yan Ma Long-Yan Yang Ying-Mei Feng Dong Zhao |
| author_facet | Cai-Guo Yu Ning Zhang Sha-Sha Yuan Yan Ma Long-Yan Yang Ying-Mei Feng Dong Zhao |
| author_sort | Cai-Guo Yu |
| collection | DOAJ |
| description | Despite being featured as metabolic disorder, diabetic patients are largely affected by hyperglycemia-induced vascular abnormality. Accumulated evidence has confirmed the beneficial effect of endothelial progenitor cells (EPCs) in coronary heart disease. However, antivascular endothelial growth factor (anti-VEGF) treatment is the main therapy for diabetic retinopathy and nephropathy, indicating the uncertain role of EPCs in the pathogenesis of diabetic microvascular disease. In this review, we first illustrate how hyperglycemia induces metabolic and epigenetic changes in EPCs, which exerts deleterious impact on their number and function. We then discuss how abnormal angiogenesis develops in eyes and kidneys under diabetes condition, focusing on “VEGF uncoupling with nitric oxide” and “competitive angiopoietin 1/angiopoietin 2” mechanisms that are shared in both organs. Next, we dissect the nature of EPCs in diabetic microvascular complications. After we overview the current EPCs-related strategies, we point out new EPCs-associated options for future exploration. Ultimately, we hope that this review would uncover the mysterious nature of EPCs in diabetic microvascular disease for therapeutics. |
| format | Article |
| id | doaj-art-437d64960c1445dba6c336ac68084521 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-437d64960c1445dba6c336ac680845212025-02-03T05:49:37ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/18039891803989Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Cai-Guo Yu0Ning Zhang1Sha-Sha Yuan2Yan Ma3Long-Yan Yang4Ying-Mei Feng5Dong Zhao6Beijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaBeijing Key Laboratory of Diabetes Prevention and Research, Luhe Hospital, Capital Medical University, Beijing 101149, ChinaDespite being featured as metabolic disorder, diabetic patients are largely affected by hyperglycemia-induced vascular abnormality. Accumulated evidence has confirmed the beneficial effect of endothelial progenitor cells (EPCs) in coronary heart disease. However, antivascular endothelial growth factor (anti-VEGF) treatment is the main therapy for diabetic retinopathy and nephropathy, indicating the uncertain role of EPCs in the pathogenesis of diabetic microvascular disease. In this review, we first illustrate how hyperglycemia induces metabolic and epigenetic changes in EPCs, which exerts deleterious impact on their number and function. We then discuss how abnormal angiogenesis develops in eyes and kidneys under diabetes condition, focusing on “VEGF uncoupling with nitric oxide” and “competitive angiopoietin 1/angiopoietin 2” mechanisms that are shared in both organs. Next, we dissect the nature of EPCs in diabetic microvascular complications. After we overview the current EPCs-related strategies, we point out new EPCs-associated options for future exploration. Ultimately, we hope that this review would uncover the mysterious nature of EPCs in diabetic microvascular disease for therapeutics.http://dx.doi.org/10.1155/2016/1803989 |
| spellingShingle | Cai-Guo Yu Ning Zhang Sha-Sha Yuan Yan Ma Long-Yan Yang Ying-Mei Feng Dong Zhao Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? Stem Cells International |
| title | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| title_full | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| title_fullStr | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| title_full_unstemmed | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| title_short | Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes? |
| title_sort | endothelial progenitor cells in diabetic microvascular complications friends or foes |
| url | http://dx.doi.org/10.1155/2016/1803989 |
| work_keys_str_mv | AT caiguoyu endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT ningzhang endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT shashayuan endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT yanma endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT longyanyang endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT yingmeifeng endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes AT dongzhao endothelialprogenitorcellsindiabeticmicrovascularcomplicationsfriendsorfoes |